|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1400 Crystal Drive |
Address2 | Suite 540 |
| City | Arlington |
State | VA |
Zip Code | 22202 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401040928-12
|
||||||||
|
6. House ID# 422410000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: MaryAnne Sapio |
Date | 4/18/2025 2:56:47 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1616 - Promoting Access to Diabetic Shoes Act
S. 717 - Increasing Access to Quality Cardiac Rehabilitation Care Act
H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act
ACO Assignment Improvement Act
Medical Nutrition Therapy Act
H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act
H.R. 2586 - Reentry Act of 2025
H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
S. 683 - More Behavioral Health Providers Act
Future Advancement of Academic Nursing (FAAN) Act
H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act
H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025
S. 1261 - CONNECT for Health Act
H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act
Primary and Behavioral Health Care Access Act
Skilled nursing facility admitting examination and assessment requirements
Reducing regulatory burdens, including those relating to Medicare Conditions of Participation
Medicare provider reimbursement
Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization
Nursing faculty and workforce shortage
Nursing education
Include nurses, APRNs, and nursing students in all national public health plans
Rural health care issues, including rural workforce and reimbursement
Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs
Medicaid reform
Issues related to Medicare Part B reform
Issues related to enhancing access to care at home in rural and underserved communities
Public health and nursing workforce infrastructure
Medication-Assisted Treatment (MATs)
Issues relating to the mental and substance use disorder workforce
Opioid epidemic
Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425]
Site specific restrictions on providers under DEA controlled substances policy
Telehealth, remote patient monitoring and other forms of health technology
Primary care payment reform
Documentation of medical records
Reauthorization of Title VIII Nursing Workforce Development Programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MaryAnne |
Sapio |
|
|
|
Jessica |
Talbert |
|
|
|
Franklin |
Harrington |
|
|
|
Adam |
Horgan |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs
Funding for Fiscal Year 2026 for the National Institute of Nursing Research
Funding for Fiscal Year 2025 for Title VIII Nursing Workforce Development Programs
Funding for Fiscal Year 2025 for the National Institute of Nursing Research
H.R.1968 - Full -Year Continuing Appropriations and Extensions Act, 2025
H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Support funding for the National Health Service Corps
Removal of burdensome Medicare requirements pertaining to nurse practitioners
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MaryAnne |
Sapio |
|
|
|
Jessica |
Talbert |
|
|
|
Franklin |
Harrington |
|
|
|
Adam |
Horgan |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
The Improving Access to Workers Compensation for Injured Federal Workers Act
Provider neutral language in federal forms, documents and surveys
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MaryAnne |
Sapio |
|
|
|
Jessica |
Talbert |
|
|
|
Franklin |
Harrington |
|
|
|
Adam |
Horgan |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1616 - Promoting Access to Diabetic Shoes Act
S. 717 - Increasing Access to Quality Cardiac Rehabilitation Care Act
H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act
ACO Assignment Improvement Act
Medical Nutrition Therapy Act
H.R. 2509/S. 931- Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act
H.R. 2586 - Reentry Act of 2025
H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
S. 683 - More Behavioral Health Providers Act
S. 1261 - CONNECT for Health Act
H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act
Skilled nursing facility admitting examination and assessment requirements
Reducing regulatory burdens, including those relating to Medicare Conditions of Participation
Medicare provider reimbursement
Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs
Medicaid reform
Issues related to Medicare Part B reform
Issues related to enhancing access to care at home in rural and underserved communities
Public health and nursing workforce infrastructure
Telehealth, remote patient monitoring and other forms of health technology
Primary care payment reform
Documentation of medical records
Medication-Assisted Treatment (MATs)
Issues relating to the mental and substance use disorder workforce
Opioid epidemic
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MaryAnne |
Sapio |
|
|
|
Jessica |
Talbert |
|
|
|
Franklin |
Harrington |
|
|
|
Adam |
Horgan |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Advanced Practice Nursing full practice authority in the Veterans Health Administration
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MaryAnne |
Sapio |
|
|
|
Jessica |
Talbert |
|
|
|
Franklin |
Harrington |
|
|
|
Adam |
Horgan |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Taxation of non-profit organizations
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
MaryAnne |
Sapio |
|
|
|
Jessica |
Talbert |
|
|
|
Franklin |
Harrington |
|
|
|
Adam |
Horgan |
|
|
|
Andrea |
Bergman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |